What's happening
This bill classifies tianeptine sodium as a Schedule II controlled substance in New York.
Why it matters
Classifying tianeptine sodium as a Schedule II controlled substance means it is recognized as having a high potential for abuse, with use potentially leading to severe psychological or physical dependence. This change would impose stricter regulations on its prescription, distribution, and possession in New York.
The amendment reflects growing concerns about tianeptine’s misuse and associated health risks, including reports of addiction, withdrawal symptoms, and overdose cases elsewhere in the U.S. By controlling the substance, New York aims to address possible public health and safety threats before they escalate.
Healthcare providers, pharmacies, and patients would face new legal requirements and oversight regarding tianeptine sodium. This could impact access for any legitimate medical uses, and may also influence research, as stricter protocols would be needed for handling and studying the substance.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Tianeptine sodium sellers
The bill would place the substance they sell under Schedule II controls.
People using tianeptine sodium
The bill would classify the substance they use as a Schedule II controlled substance.
Controlled-substance regulators
The bill would add tianeptine sodium to New York’s Schedule II list.
Headline styles
Ban Tianeptine Sodium Sales
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 26
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Restrict Tianeptine Sodium Use
In Senate Committee · Health · Sponsor James Skoufis
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
344
2021-2022 Regular Sessions
IN ASSEMBLY (Prefiled)
January 6, 2021
Introduced by M. of A. BRAUNSTEIN -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:
(5) Tianeptine sodium.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03419-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.